Fundraising FoxPrevail Therapeutics
New York, US · Founded 2017 · Delaware corporation · 5 known investors
Find your way into Prevail Therapeutics
Founders & leadership
Prevail Therapeutics was founded in 2017 by ASA ABELIOVICH.
Board
PT
MA
CG
Investors · 5
AlexandriareportedPasadena
How we know: funding news · press coverage · Not right? Tell us
Biotechnology Value FundreportedSan Francisco
How we know: press coverage · Not right? Tell us
EcoR1 CapitalreportedSan Francisco
How we know: funding news · press coverage · Not right? Tell us
OrbiMedreportedNew York · $1M – $75Mvia Mona Ashiya · board
How we know: board seat on SEC Form D · funding news · press coverage · Not right? Tell us
RA CapitalreportedBoston
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$57M disclosed across 1 of 2 rounds · 2018–2019
- Undisclosed amountSeries BMar 2019Source ↗
▶$57MraisedMar 2018 · 15 investors · Other Health CareRule 506(b)
▶$57MraisedMar 2018 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- PETER THOMPSONDirector
- MONA ASHIYADirector
- CARL GORDONDirector
- ASA ABELIOVICHExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $57M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Prevail Therapeutics?
- Prevail Therapeutics was founded by ASA ABELIOVICH in 2017.
- Who are Prevail Therapeutics's investors?
- Prevail Therapeutics's investors include Alexandria, Biotechnology Value Fund, EcoR1 Capital, OrbiMed, RA Capital.
- How much funding has Prevail Therapeutics raised?
- Prevail Therapeutics has disclosed $57M raised across 1 of its 2 known rounds.
- Where is Prevail Therapeutics headquartered?
- Prevail Therapeutics is headquartered in New York, US.